Abstract
Intracellular glutathione-triggered doxorubicin release from silica nanotubes with hydrophobic labile cap was demonstrated for the drug-resistant cancer cell treatment.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibiotics, Antineoplastic / administration & dosage
-
Antibiotics, Antineoplastic / toxicity
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Doxorubicin / administration & dosage
-
Doxorubicin / toxicity
-
Drug Carriers / chemistry*
-
Drug Resistance, Neoplasm
-
Glutathione / chemistry
-
Glutathione / metabolism*
-
Humans
-
Hydrophobic and Hydrophilic Interactions
-
MCF-7 Cells
-
Mice
-
Mice, Nude
-
Nanotubes / chemistry*
-
Neoplasms / drug therapy
-
Silicon Dioxide / chemistry*
-
Transplantation, Heterologous
Substances
-
Antibiotics, Antineoplastic
-
Drug Carriers
-
Silicon Dioxide
-
Doxorubicin
-
Glutathione